In an ancillary study ofthe BARI 2D trial [22], which evaluated a population of patients with diabetesand stable ischemic heart disease, lower concentrations of hs-cTnT observed infemales were associated with an elevated risk of major cardiovascular (CV) eventsand death compared with males with similar hs-cTnT levels. The gene discussed is TNNT2; the disease is coronary artery disorder.